Early Esophageal Cancer And Pre Cancer Eliminated With Non Surgical Treatment Combination

BARRX Medical, Inc., a global technology leader in treating Barrett’s esophagus, announced the publication of two related European trials which report a 100% eradication rate for early esophageal cancer and pre-cancerous dysplasia using endoscopic resection followed by ablation therapy with the HALO ablation system.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on June 1st, 2008